NYSE - Delayed Quote USD

Solventum Corporation (SOLV)

70.23
+3.60
+(5.40%)
At close: May 9 at 4:00:01 PM EDT
70.20
-0.03
(-0.04%)
After hours: May 9 at 7:52:32 PM EDT
Loading Chart for SOLV
  • Previous Close 66.63
  • Open 67.96
  • Bid --
  • Ask --
  • Day's Range 66.91 - 71.08
  • 52 Week Range 47.16 - 85.92
  • Volume 1,823,623
  • Avg. Volume 1,239,603
  • Market Cap (intraday) 12.15B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 32.36
  • EPS (TTM) 2.17
  • Earnings Date Aug 4, 2025 - Aug 19, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 80.14

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates in four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment offers solutions for negative pressure wound therapy, advanced wound dressings, advanced skin care, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wrap, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. Its Dental Solutions segment provides a suite of dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions and services for health care systems, such as computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. Its Purification and Filtration segment provides purification and filtration technologies comprising filters, purifiers, cartridges, and membranes. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is based in Maplewood, Minnesota.

www.solventum.com

22,000

Full Time Employees

December 31

Fiscal Year Ends

Recent News: SOLV

View More

Performance Overview: SOLV

Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

SOLV
6.31%
S&P 500 (^GSPC)
3.77%

1-Year Return

SOLV
8.33%
S&P 500 (^GSPC)
8.55%

3-Year Return

SOLV
1.56%
S&P 500 (^GSPC)
41.81%

5-Year Return

SOLV
1.56%
S&P 500 (^GSPC)
93.18%

Compare To: SOLV

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: SOLV

View More

Valuation Measures

As of 5/9/2025
  • Market Cap

    12.15B

  • Enterprise Value

    19.53B

  • Trailing P/E

    32.36

  • Forward P/E

    12.66

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.47

  • Price/Book (mrq)

    3.72

  • Enterprise Value/Revenue

    2.35

  • Enterprise Value/EBITDA

    15.13

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    4.56%

  • Return on Assets (ttm)

    3.84%

  • Return on Equity (ttm)

    10.66%

  • Revenue (ttm)

    8.31B

  • Net Income Avi to Common (ttm)

    379M

  • Diluted EPS (ttm)

    2.17

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    534M

  • Total Debt/Equity (mrq)

    242.58%

  • Levered Free Cash Flow (ttm)

    1.06B

Research Analysis: SOLV

View More

People Also Watch